---
figid: PMC9253705__gr7
pmcid: PMC9253705
image_filename: gr7.jpg
figure_link: /pmc/articles/PMC9253705/figure/f0035/
number: Fig. 7
figure_title: ''
caption: Pexmetinib suppresses osteoclast formation and breast cancer metastasis via
  P38/STAT3 signal pathway. A graph abstract showing the working model of the role
  of Pexmetinib in inhibiting osteoclastogenesis and breast cancer metastasis.
article_title: Pexmetinib suppresses osteoclast formation and breast cancer induced
  osteolysis via P38/STAT3 signal pathway.
citation: Zhiwei Jie, et al. J Bone Oncol. 2022 Aug;35:100439.
year: '2022'

doi: 10.1016/j.jbo.2022.100439
journal_title: Journal of Bone Oncology
journal_nlm_ta: J Bone Oncol
publisher_name: Elsevier

keywords:
- P38 mitogen-activated protein kinase
- Pexmetinib
- Osteoclast
- Breast cancer
- Osteolysis

---
